profile

A seasoned professional with over eight years of experience at the intersection of corporate law, mergers and acquisitions, and scientific innovation, Wenwen is a distinguished strategist and leader. She combines a deep understanding of legal and regulatory frameworks with a background in pharmaceutical science and a forward-thinking approach to technology governance. Her career is marked by a unique ability to navigate complex, high-stakes environments, from multi-billion dollar M&A transactions to pioneering work in AI risk management.

As a strategic advisor, Wenwen has been instrumental in some of the most prominent transactions in U.S. sports and corporate law. She helped lead the legal, public relations, and deal strategy for Steve Cohen’s landmark $2.4 billion acquisition of the New York Mets, the largest in U.S. sports history. Her expertise extends to litigation and risk management, where she was involved in a RICO case against Major League Baseball and led a class-action lawsuit against a financing firm and over 20 auto dealers. She also provided support for defamation and malpractice lawsuits for public figures, including Lenny Dykstra. Her work as an M&A Advisor at MergersCorp demonstrates her command of the entire transaction lifecycle, from due diligence and negotiation to post-closing integration, with a focus on regulatory compliance.

Complementing her legal career is a solid foundation in science and healthcare, cultivated during her time as a research analyst and project manager at Pfizer. In this role, she supported documentation for due diligence processes and post-acquisition product transfers. During the COVID-19 pandemic, her expertise was crucial in supporting the White House’s response efforts and in securing Emergency Use Authorization (EUA) from the FDA for COVID test kits. Her experience also includes contributions to a significant drug licensing deal for Amgen and extensive knowledge of FDA and SEC filings.

Recognizing the evolving challenges of a technology-driven world, Wenwen created RADAR, an AI governance scoring model that systematically flags regulatory risk. This innovative tool assesses a firm’s AI readiness and has been applied in M&A due diligence, policy evaluations, and compliance audits, reducing due diligence time by up to 40%. As the Chief Governance Strategist at RADAR Governance, she has positioned this solution as a critical bridge between corporate strategy, public policy, and emerging regulation.

Through her unique combination of legal precision, business strategy, and systems thinking, Wenwen has consistently demonstrated her capacity to drive successful outcomes in dynamic and highly regulated industries.